Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Fair enough. Uplisting is the one thing that I wish Leo could have done differently. But unlike a failed clinical trial, this uplist problem can be fixed when the SP recovers. Being on pink hasn't affected the progress of the clinical trials. This is why I think the uplist mistake isn't that "critical". If a drug doesn't work, it doesn't work, regardless of the exchange.